Regulatory FDA moves toward easing restrictions on certain peptides BioPharma DiveThe agency s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F.RegulatoryRead full story pharminent April 16, 2026 (Last updated: April 17, 2026) BioPharma Dive The agency s decision to hold an advisory committee meeting on the topic comes after HHS Secretary Robert F. RegulatoryRead full story Post navigation Previous: Lilly’s new obesity pill passes heart safety test in diabetesNext: Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director Related Stories Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026 Regulatory HHS appoints permanent FDA CBER, CDER heads pharminent September 10, 2026 Regulatory FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer pharminent September 7, 2026